Literature DB >> 2239369

T lymphocyte surface antigen markers in osteoporosis.

C J Rosen1, K Usiskin, M Owens, C O Barlascini, M Belsky, R A Adler.   

Abstract

Two distinct syndromes of osteoporosis have been postulated: type I, which is characterized by accelerated bone loss occurring in women during the early postmenopausal period; and type II, an age-related process of bone loss affecting both men and women in and after the seventh decade. Recently there has been indirect evidence linking local products of the immune system with bone remodeling. We therefore studied peripheral blood profiles of specific lymphocyte phenotypes in women with type I osteoporosis and in older women and men with type II osteoporosis. The ratio of CD4-bearing (T helper) cells to CD8-bearing (T cytotoxic-suppressor) cells (CD4/CD8 ratio) was elevated in women with symptomatic type I disease. In addition there was a significant negative correlation (r = -0.62, P less than 0.001) between the CD4/CD8 ratio and the spinal bone mineral density measured by dual-photon absorptiometry. In contrast, older men with a history of fracture (hip or spine) had CD4/CD8 ratios similar to control men. The number of T cells bearing IL-2R or VLA-1 was not different between osteoporotic subjects and controls in either men or women. This study supports the concept that local products of the immune system may be directly or indirectly involved in the pathogenesis of type I osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2239369     DOI: 10.1002/jbmr.5650050808

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  6 in total

Review 1.  Cytokines in the pathogenesis of osteoporosis.

Authors:  E Romas; T J Martin
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

2.  Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo.

Authors:  C Roggia; Y Gao; S Cenci; M N Weitzmann; G Toraldo; G Isaia; R Pacifici
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

3.  Premature T cell senescence in Ovx mice is inhibited by repletion of estrogen and medicarpin: a possible mechanism for alleviating bone loss.

Authors:  A M Tyagi; K Srivastava; J Kureel; A Kumar; A Raghuvanshi; D Yadav; R Maurya; A Goel; D Singh
Journal:  Osteoporos Int       Date:  2011-05-12       Impact factor: 4.507

4.  Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor.

Authors:  N J Horwood; N Udagawa; J Elliott; D Grail; H Okamura; M Kurimoto; A R Dunn; T Martin; M T Gillespie
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

5.  Daidzein prevents the increase in CD4+CD28null T cells and B lymphopoesis in ovariectomized mice: a key mechanism for anti-osteoclastogenic effect.

Authors:  Abdul Malik Tyagi; Kamini Srivastava; Kunal Sharan; Dinesh Yadav; Rakesh Maurya; Divya Singh
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

6.  Multivariate Comparison of Cytokine Profiles for Normal- and Low-Bone-Density Subjects.

Authors:  Kamaludin Dingle; Fawaz Azizieh
Journal:  Diagnostics (Basel)       Date:  2019-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.